DOI QR코드

DOI QR Code

The relationship between uric acid and anemia in Korean adults with chronic kidney disease

국내 만성신장질환자에서 나타나는 요산과 빈혈과의 관련성

  • Seung Bum Yang (Dep. of Medical Non-commissioned Officer, Wonkwang Health Science University)
  • 양승범 (원광보건대학교 의무부사관과)
  • Received : 2023.04.16
  • Accepted : 2023.05.20
  • Published : 2023.07.31

Abstract

The present study was conducted to assess the relationship between hyperuricemia and anemia in Korean adults with chronic kidney disease (CKD). Data from 557 adults (age ≥ 20 years) in the Eighth Korean National Health and Nutrition Examination Survey (2019-2021) were analyzed. Several key findings were identified. First, after adjusting for the related variables, the odds ratio (OR) of anemia (hemoglobin [Hb] < 13.0 mg/dL in men or < 12 mg/dL in women), using the normouricemia group (uric acid [UA] < 7.0 mg/dL in men or < 6.0 mg/dL in women) as a reference, was positively significant for the hyperuricemia group (uric acid [UA] ≥ 7.0 mg/dL in men or ≥ 6.0 mg/dL in women) in overall population (odds ratio [OR], 1.719; 95% confidence interval [CI], 1.371-2.942), men (OR, 2.008; 95% CI, 1.013-3.165), and women (OR, 2.246; 95% CI, 1.315-3.835). In conclusions, hyperuricemia was associated with an increase in anemia in both Korean men and women with chronic kidney disease.

본 연구는 만성신장질환이 있는 한국 성인의 고요산혈증과 빈혈과의 관계를 알아보기 위해 제8기 국민건강 영양조사(2019~2021)를 바탕으로 20세 이상의 성인 557명의 자료를 분석했다. 본 연구에서는 몇 가지 주요한 결과가 있었다. 관련 변수를 조정한 후, 정상요산군(남성, 요산[uric acid, UA] < 7.0 mg/dL; 여성, UA < 6.0 mg/dL)에 비하여 고요산혈증군(남성, UA ≥ 7.0 mg/dL; 여성, UA ≥ 6.0 mg/dL)의 빈혈 발생 교차비(odds ratio, OR)는 남성(OR, 2.008; 95% confidence interval [CI], 1.013-3.165)과 여성(OR, 2.246; 95% CI, 1.315 -3.835) 및 만성신장질환 전체(OR, 1.719; 95% CI, 1.371-2.942)에서 유의하게 높았다. 결론적으로 고요산혈증은 만성신장질환을 가진 한국인 남녀 모두에서 빈혈 증가와 관련이 있었다.

Keywords

Acknowledgement

본 논문은 원광보건대학교 연구과제(2023년)로 수행되었음.

References

  1. A. J. Madu and M. D. Ughasoro. 'Anaemia of Chronic Disease: An In-Depth Review'. Med Princ Pract, vol.26, no.1, pp.1-9, 2017.
  2. E. McLean, M. Cogswell, I. Egli, D. Wojdyla and B. de Benoist. 'Worldwide prevalence of anaemia, who vitamin and mineral nutrition information system, 1993-2005'. Public Health Nutr, vol.12, no.4, pp.444-454, 2009.
  3. E. Nemeth and T. Ganz. 'Anemia of inflammation'. Hematol Oncol Clin North Am. vol.28, no.4, pp.671-681, 2014.
  4. Begum S, Latunde-Dada GO. 'Anemia of Inflammation with An Emphasis on Chronic Kidney Disease'. Nutrients. vol.11, no.10, pp.e2424, 2019.
  5. B. C. Astor, J. Coresh, G. Heiss, D. Pettitt and M. J. Sarnak. 'Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study'. Am Heart J. vol.151, no.2, pp.492-500, 2006.
  6. Mozos I. 'Mechanisms linking red blood cell disorders and cardiovascular diseases'. Biomed Res Int. vol.2015, pp.e682054, 2015.
  7. S. Zhang, Y. Wang, J. Cheng, N. Huangfu, R. Zhao, Z. Xu, F. Zhang, W. Zheng and D. Zhang. 'Hyperuricemia and Cardiovascular Disease'. Curr Pharm Des. vol.25, no.6, pp.700-709, 2019.
  8. L. Shahin, K-M. Patel, M-K. Heydari and M-M Kesselman. 'Hyperuricemia and Cardiovascular Risk'. Cureus. vol.13, no.5, pp.e14855, 2021.
  9. R. Spiga, M. A. Marini, E. Mancuso, C. Di Fatta, A. Fuoco, F. Perticone, F. Andreozzi, G. C. Mannino and G. Sesti. 'Uric Acid Is Associated With Inflammatory Biomarkers and Induces Inflammation Via Activating the NF-κB Signaling Pathway in HepG2 Cells'. Arterioscler Thromb Vasc Biol. vol.37, no.3, pp.1241-1249, 2017.
  10. J. G. Mohanty, E. Nagababu and J. M Rifkind. 'Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging'. Front Physiol. vol.5, pp.e84, 2014.
  11. E. Nemeth and T. Ganz. 'Anemia of inflammation'. Hematol Oncol Clin North Am. vol.28, no.4, pp.671-681, 2014.
  12. Y. Song, L. Tang, J. Han, Y. Gao, B. Tang, M. Shao, W. Yuan, W. Ge, X. Huang, T. Yao, X. Bian, S. Li, W. Cao and H Zhang. 'Uric Acid Provides Protective Role in Red Blood Cells by Antioxidant Defense: A Hypothetical Analysis'. Oxid Med Cell Longev, vol.2019, pp.e3435174, 2019.
  13. S. E. Shoelson, J. Lee and A. B. Goldfine. 'Inflammation and insulin resistance'. J Clin Invest. vol.116, no.7, pp.1793-1801, 2006.
  14. Su P, Hong L, Zhao Y, Sun H, Li L. 'The Association Between Hyperuricemia and Hematological Indicators in a Chinese Adult Population'. Medicine (Baltimore). vol.95, no.7, pp.e2822, 2016.
  15. P. K. Uduagbamen, J. O. Ogunkoya, A. O. AdebolaYusuf, A. T. Oyelese, C. I. Nwogbe, C. J. Ofoh and C. Anyaele. 'Hyperuricemia in Hypertension and Chronic Kidney Disease: Risk Factors, Prevalence and Clinical Correlates: A Descriptive Comparative Study'. International Journal of Clinical Medicine. vol.12, pp.386-401, 2021.
  16. J. Xu, L. Tong and J Mao. 'Hyperuricemia and Associated Factors in Children with Chronic Kidney Disease: A Cross-Sectional Study'. Children (Basel). vol.9, no.1, pp.e6, 2021.
  17. E. Nemeth and T. Ganz. 'Anemia of inflammation'. Hematol Oncol Clin North Am. vol.28, no.4, pp. 671-681, 2014.
  18. Y-H. Eun, K-D. Han, D-H. Kim, I-Y. Kim, E- J. Park, S-K. Lee, H-S. Cha, E-M. Koh, J. Lee and H. Kim. 'Association between anemia and hyperuricemia: results from the Korean National Health and Nutrition Examination Survey.' Sci Rep. vol.9, no.1, pp.e19067, 2019.
  19. A. Pietrangelo. 'Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years Since Hepcidin'. Gastroenterology. vol.149, no.5, pp.1240-1251, 2015.
  20. A. Pagani, A. Nai, L. Silvestri and C. Camaschella. 'Hepcidin and Anemia: A Tight Relationship'. Front Physiol. vol.10, pp.e1294, 2019.